Bespoke Extracts, Inc., operating as The Joint Company, announced its strongest operational and financial performance in the third quarter of 2025.
The company's disciplined execution, brand trust, and efficient manufacturing processes led to significant growth.
Key highlights include record revenue, improved gross margins, and a narrowed net loss compared to the previous year.
Record Revenue
$467,945, up 19.8% from Q2 2025 and 68.6% year-over-year.
Improved Gross Margin
50.0%, up 860 basis points versus the prior year, driven by operational efficiencies.
Net Loss Reduction
GAAP net loss narrowed to $78,088, a 72% improvement from Q3 2024.
Production Growth
209,600 pre-rolls produced during the quarter, marking an 81% increase year-over-year.
Strategic Success
Demonstrable progress on revenue, distribution, and branded products according to the 2025 plan.
- The company's focus on efficiency, quality, and innovation propelled record growth.
- Operational excellence and continual improvement through data and iteration were highlighted.
- The results demonstrate resilience and innovation within The Joint Company.
- The strategic success in Colorado's cannabis market sets the company apart from competitors.
Bespoke Extracts, Inc.'s outstanding performance and strategic planning position them for continued success in the cannabis market. Their focus on quality, efficiency, and scalability is commendable, reflecting operational excellence and growth potential.